Hikma Pharmaceuticals PLC (LON:HIK – Get Rating) has been assigned an average rating of “Moderate Buy” from the seven analysts that are currently covering the firm, Marketbeat Ratings reports. Three research analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 12 month price […]
Related Keywords
Canada , , Analyst Recommendations For Hikma Pharmaceuticals , Royal Bank , Berenberg Bank , Jefferies Financial Group , News Ratings For Hikma Pharmaceuticals Daily , Jpmorgan Chase Co , Hikma Pharmaceuticals Increases Dividend , Hikma Pharmaceuticals Price Performance , Hikma Pharmaceuticals , Citigroup , Get Rating , Marketbeat Ratings , Financial Group , Hikma Pharmaceuticals Daily , Lon Hik , Zhik , Medical , Ratings , Consensus ,
comparemela.com © 2020. All Rights Reserved.